Speaking to CNBC-TV18, Arjun Handa, managing director & CEO of Claris Lifesciences said."We have had very productive meeting with the US FDA and are hopeful of resolving the issue very soon. We don’t see this as very big hurdle for the company."
first published: Feb 25, 2011 11:51 am
A collection of the most-viewed Moneycontrol videos.

Markets Beyond The Budget : What Next For Indian Investors ?

Nifty Braces For Further Pain As FIIs Return|Big Market Voices Decode STT Shock | Opening Bell Live

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell

Govt to stick to the path of fiscal consolidation - Prof Dev, PMEC chairman
You are already a Moneycontrol Pro user.
